{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T13:34:15Z","timestamp":1790861655930,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,22]],"date-time":"2013-07-22T00:00:00Z","timestamp":1374451200000},"content-version":"vor","delay-in-days":568,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.canlet.2011.09.019","type":"journal-article","created":{"date-parts":[[2011,9,25]],"date-time":"2011-09-25T16:35:12Z","timestamp":1316968512000},"page":"108-118","source":"Crossref","is-referenced-by-count":28,"title":["Both XPA and DNA polymerase eta are necessary for the repair of doxorubicin-induced DNA lesions"],"prefix":"10.1016","volume":"314","author":[{"given":"Maria Carolina S.","family":"Moraes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annabel Quinet","family":"de Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helotonio","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Temenouga","family":"Guecheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mateus H.","family":"Agnoletto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o A.P.","family":"Henriques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Sarasin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Stary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenifer","family":"Saffi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos F.M.","family":"Menck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2011.09.019_b0005","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0006-2952(98)00307-4","article-title":"A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin","volume":"57","author":"Gewirtz","year":"1999","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.canlet.2011.09.019_b0010","doi-asserted-by":"crossref","DOI":"10.1091\/mbc.E08-03-0306","article-title":"DNA-ligase IV and DNA-PK play a critical role in deficient caspases activation in apoptosis-resistant cancer cells using doxorubicin","author":"Friesen","year":"2008","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.canlet.2011.09.019_b0015","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.biochi.2003.10.017","article-title":"The eukaryotic nucleotide excision repair pathway","volume":"85","author":"Costa","year":"2003","journal-title":"Biochimie"},{"key":"10.1016\/j.canlet.2011.09.019_b0020","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1111\/j.1742-4658.2006.05189.x","article-title":"The protein shuffle. Sequential interactions among components of the human nucleotide excision repair pathway","volume":"273","author":"Park","year":"2006","journal-title":"Febs J."},{"key":"10.1016\/j.canlet.2011.09.019_b0025","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1034\/j.1600-0625.2003.00124.x","article-title":"Molecular genetics of Xeroderma pigmentosum variant","volume":"12","author":"Gratchev","year":"2003","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.canlet.2011.09.019_b0030","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s00280-010-1244-x","article-title":"DNA damage induced by the anthracycline cosmomycin D in DNA repair-deficient cells","volume":"65","author":"Carvalho","year":"2010","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.canlet.2011.09.019_b0035","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.dnarep.2009.10.003","article-title":"Effect of the anti-neoplastic drug doxorubicin on XPD-mutated DNA repair-deficient human cells","volume":"9","author":"Saffi","year":"2010","journal-title":"DNA Repair (Amst)"},{"key":"10.1016\/j.canlet.2011.09.019_b0040","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1038\/sj.onc.1209201","article-title":"The PI3K inhibitor LY294002 blocks drug export from resistant colon carcinoma cells overexpressing MRP1","volume":"25","author":"Abdul-Ghani","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2011.09.019_b0045","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1002\/ijc.23671","article-title":"Enhanced anti-cancer effect of a phosphatidylinositol-3 kinase inhibitor and doxorubicin on human breast epithelial cell lines with different p53 and oestrogen receptor status","volume":"123","author":"Wang","year":"2008","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2011.09.019_b0050","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S1568-7864(03)00088-0","article-title":"p21 and Bax by pifithrin-alpha does not affect UV induced apoptotic response in CS-B cells","volume":"2","author":"Proietti De Santis","year":"2003","journal-title":"DNA Repair (Amst)"},{"key":"10.1016\/j.canlet.2011.09.019_b0055","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.tiv.2005.12.008","article-title":"Microelectronic cell sensor assay for detection of cytotoxicity and prediction of acute toxicity","volume":"20","author":"Xing","year":"2006","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.canlet.2011.09.019_b0060","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.aca.2008.03.047","article-title":"A cell-microelectronic sensing technique for profiling cytotoxicity of chemicals","volume":"615","author":"Boyd","year":"2008","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.canlet.2011.09.019_b0065","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1007\/s00262-009-0700-0","article-title":"Breast tumor cells isolated from in vitro resistance to trastuzumab remain sensitive to trastuzumab anti-tumor effects in vivo and to ADCC killing","volume":"58","author":"Kute","year":"2009","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.canlet.2011.09.019_b0070","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1124\/jpet.110.169128","article-title":"Novel small-molecule inhibitor of apurinic\/apyrimidinic endonuclease 1 blocks proliferation and reduces viability of glioblastoma cells","volume":"334","author":"Bapat","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.canlet.2011.09.019_b0075","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1046\/j.1523-1747.1998.00171.x","article-title":"Homozygous R788W point mutation in the XPF gene of a patient with xeroderma pigmentosum and late-onset neurologic disease","volume":"110","author":"Sijbers","year":"1998","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.canlet.2011.09.019_b0080","doi-asserted-by":"crossref","first-page":"5241","DOI":"10.1016\/S0021-9258(17)37680-9","article-title":"A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002)","volume":"269","author":"Vlahos","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2011.09.019_b0085","first-page":"1149","article-title":"Radiosensitization of human tumor cells by the phosphatidylinositol3-kinase inhibitors wortmannin and LY294002 correlates with inhibition of DNA-dependent protein kinase and prolonged G2-M delay","volume":"3","author":"Rosenzweig","year":"1997","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2011.09.019_b0090","first-page":"2581","article-title":"Competitive and noncompetitive inhibition of the DNA-dependent protein kinase","volume":"59","author":"Izzard","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2011.09.019_b0095","doi-asserted-by":"crossref","first-page":"6707","DOI":"10.1038\/sj.onc.1203077","article-title":"ATR is a caffeine-sensitive, DNA-activated protein kinase with a substrate specificity distinct from DNA-PK","volume":"18","author":"Hall-Jackson","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2011.09.019_b0100","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1158\/0008-5472.CAN-03-3207","article-title":"ATM and DNA-PK function redundantly to phosphorylate H2AX after exposure to ionizing radiation","volume":"64","author":"Stiff","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2011.09.019_b0105","doi-asserted-by":"crossref","first-page":"R473","DOI":"10.1016\/j.cub.2005.06.012","article-title":"DNA repair: how to PIKK a partner","volume":"15","author":"Hiom","year":"2005","journal-title":"Curr. Biol."},{"key":"10.1016\/j.canlet.2011.09.019_b0110","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1038\/emboj.2009.281","article-title":"Emerging common themes in regulation of PIKKs and PI3Ks","volume":"28","author":"Lempiainen","year":"2009","journal-title":"EMBO J."},{"key":"10.1016\/j.canlet.2011.09.019_b0115","first-page":"6089","article-title":"Enzyme-activated prodrug therapy enhances tumor-specific replication of adenovirus vectors","volume":"62","author":"Bernt","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2011.09.019_b0120","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1038\/sj.bjc.6603189","article-title":"Different susceptibility of osteosarcoma cell lines and primary cells to treatment with oncolytic adenovirus and doxorubicin or cisplatin","volume":"94","author":"Graat","year":"2006","journal-title":"Br J. Cancer"},{"key":"10.1016\/j.canlet.2011.09.019_b0125","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0163-7258(90)90088-J","article-title":"Doxorubicin (adriamycin): a critical review of free radical-dependent mechanisms of cytotoxicity","volume":"47","author":"Keizer","year":"1990","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.canlet.2011.09.019_b0130","first-page":"661","article-title":"Sequence specificity of adriamycin-DNA adducts in human tumor cells","volume":"2","author":"Cutts","year":"2003","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.canlet.2011.09.019_b0135","doi-asserted-by":"crossref","first-page":"53272","DOI":"10.1074\/jbc.M406879200","article-title":"Doxorubicin activates ATM-dependent phosphorylation of multiple downstream targets in part through the generation of reactive oxygen species","volume":"279","author":"Kurz","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2011.09.019_b0140","doi-asserted-by":"crossref","first-page":"4863","DOI":"10.1158\/0008-5472.CAN-05-3410","article-title":"Doxorubicin-DNA adducts induce a non-topoisomerase II-mediated form of cell death","volume":"66","author":"Swift","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2011.09.019_b0145","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10565-006-0140-y","article-title":"Adriamycin-induced oxidative mitochondrial cardiotoxicity","volume":"23","author":"Berthiaume","year":"2007","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.canlet.2011.09.019_b0150","doi-asserted-by":"crossref","first-page":"9053","DOI":"10.1073\/pnas.0803513105","article-title":"Topoisomerase levels determine chemotherapy response in vitro and in vivo","volume":"105","author":"Burgess","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.canlet.2011.09.019_b0155","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.mrfmmm.2007.09.005","article-title":"DNA repair in response to anthracycline-DNA adducts: a role for both homologous recombination and nucleotide excision repair","volume":"638","author":"Spencer","year":"2008","journal-title":"Mutat. Res."},{"key":"10.1016\/j.canlet.2011.09.019_b0160","doi-asserted-by":"crossref","first-page":"729","DOI":"10.4161\/cc.9.4.10727","article-title":"Multiple two-polymerase mechanisms in mammalian translesion DNA synthesis","volume":"9","author":"Livneh","year":"2010","journal-title":"Cell Cycle"},{"key":"10.1016\/j.canlet.2011.09.019_b0165","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.molcel.2005.10.016","article-title":"Dual roles for DNA polymerase eta in homologous DNA recombination and translesion DNA synthesis","volume":"20","author":"Kawamoto","year":"2005","journal-title":"Mol. Cell"},{"key":"10.1016\/j.canlet.2011.09.019_b0170","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.molcel.2005.10.001","article-title":"Human DNA polymerase eta promotes DNA synthesis from strand invasion intermediates of homologous recombination","volume":"20","author":"McIlwraith","year":"2005","journal-title":"Mol. Cell"},{"key":"10.1016\/j.canlet.2011.09.019_b0175","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/mc.20509","article-title":"Role of TLS DNA polymerases eta and kappa in processing naturally occurring structured DNA in human cells","volume":"48","author":"Betous","year":"2009","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.canlet.2011.09.019_b0180","doi-asserted-by":"crossref","first-page":"3344","DOI":"10.1128\/MCB.00115-09","article-title":"Human DNA polymerase eta is required for common fragile site stability during unperturbed DNA replication","volume":"29","author":"Rey","year":"2009","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.canlet.2011.09.019_b0185","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.dnarep.2010.03.013","article-title":"Requirement for functional DNA polymerase eta in genome-wide repair of UV-induced DNA damage during S phase","volume":"9","author":"Auclair","year":"2010","journal-title":"DNA Repair (Amst)"},{"key":"10.1016\/j.canlet.2011.09.019_b0190","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.4161\/cc.8.20.9836","article-title":"DNA damage induced Pol eta recruitment takes place independently of the cell cycle phase","volume":"8","author":"Soria","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1016\/j.canlet.2011.09.019_b0195","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1158\/1541-7786.MCR-05-0118","article-title":"A novel role of DNA polymerase eta in modulating cellular sensitivity to chemotherapeutic agents","volume":"4","author":"Chen","year":"2006","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.canlet.2011.09.019_b0200","doi-asserted-by":"crossref","DOI":"10.1158\/1535-7163.MCT-11-0272","article-title":"BRCA mutation status and determinant of outcome in women with recurrent epithelial ovarian cancer treated with pegylated liposomal doxorubicin","author":"Safra","year":"2011","journal-title":"Mol. Cancer Ther."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383511005659?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383511005659?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,12,7]],"date-time":"2021-12-07T14:46:22Z","timestamp":1638888382000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383511005659"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0304383511005659"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2011.09.019","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}